Respiratory Insufficiency: Clinical Trials

61 trials for Respiratory Insufficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

61 completed. 61 Phase 2, 13 Phase 1, 10 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 261Completed 61
Phase 113Completed 13
Phase 310Completed 10

Follow Respiratory Insufficiency: new trials by email Literature Review of Respiratory Insufficiency trials Research Report on Respiratory Insufficiency

Trials (filtered) newest first · largest first

All 61 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults
Oxymetazoline HCl 0.05% nasal gel, Placebo nasal gel - Nasal Congestion, Nasal Obstruction
Phase 2CompletedBayer1202026-04-202026-06-08
Sedation vs No Sedation in Mechanically Ventilated COPD Patients
Midalozam - Chronic Obstructive Pulmonary Disease, Respiratory Failure
Phase 2CompletedAl-Azhar University1002025-04-142026-06-02
Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age
Remifentanil Hydrochloride, Pupillometry measurement - Opioid Toxicity, Pupillary Miosis
Phase 2 / Phase 3CompletedUniversity of California, San Francisco102022-10-012025-05-02
Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD
Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] - Tetralogy of Fallot, Pulmonary Insufficiency
Phase 1 / Phase 2CompletedNemours Children's Clinic252022-08-232026-04-27
CONFOCAL-2 Interventional Pilot Study
Autoregulation-based precision blood pressure management - Critical Illness, Respiratory Failure
Phase 1 / Phase 2CompletedQueen's University162022-07-292025-12-22
Study of AD981 Versus Placebo in Obesity Hypoventilation Syndrome
AD981, Placebo - Obesity Hypoventilation Syndrome (OHS)
Phase 2CompletedIstituto Auxologico Italiano152022-06-212025-02-27
Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery
Intravenous Acetaminophen (room temperature), Intravenous Vitamin C (refrigerated), 5% Dextrose (room temperature) - Acute Respiratory Distress Syndrome, Critical Illness
Phase 2CompletedMassachusetts General Hospital4882021-10-132024-09-27
Totally Transdermal Sedation in the Weaning From Remifentanil Infusion
Fentanyl Transdermal System, Remifentanil - Respiratory Insufficiency, Ventilator Weaning
Phase 2CompletedFondazione Policlinico Universitario Agostino Gemelli IRCCS242021-02-152024-05-17
Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)
Mesenchymal Stromal Cells, Supportive Care - Sars-CoV2, Acute Respiratory Distress Syndrome
Phase 1 / Phase 2CompletedBaylor College of Medicine282021-02-122026-10-21
Nebulised Heparin in Patients With Severe COVID-19
Nebulised unfractionated heparin (UFH) - Covid19, Respiratory Failure
Phase 2 / Phase 3CompletedAustralian National University572020-11-012025-11-05
Intravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19
L-Citrulline, Placebo - Acute Hypoxemic Respiratory Failure
Phase 2CompletedAsklepion Pharmaceuticals, LLC652020-10-152023-02-22
Tenecteplase in Patients With COVID-19
Tenecteplase, Placebo - COVID-19, Respiratory Failure
Phase 2CompletedHooman Poor132020-09-252023-04-06
Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation
Convalescent Plasma, Standard of Care - Covid19, Mechanical Ventilation Complication
Phase 2CompletedUniversity of Liege4752020-09-112024-10-29
Telmisartan in Respiratory Failure Due to COVID-19
Telmisartan - COVID-19, Respiratory Insufficiency
Phase 2CompletedAbraham Edgar Gracia-Ramos662020-08-122023-10-05
Use of Angiotensin-(1-7) in COVID-19
Angiotensin-(1-7), Placebo - Infection, Coronavirus, Respiratory Failure
Phase 1 / Phase 2CompletedErasme University Hospital1122020-08-052021-11-09
Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure
Iloprost, Isotonic saline - COVID-19, Respiratory Failure
Phase 2CompletedPär Johansson802020-06-152024-05-07
Study of Efficacy and Safety of MAS825 in Patients With COVID-19
MAS825, Placebo, Standard of Care (SoC) - COVID-19 Pneumonia, Impaired Respiratory Function
Phase 2CompletedNovartis Pharmaceuticals1402020-06-112022-08-10
Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury
Ibrutinib, Placebo - CoronaVirus Induced Disease-2019 (COVID-19)
Phase 2CompletedAbbVie462020-06-062022-06-01
Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia
DFV890, Standard of Care (SoC) - COVID-19 Pneumonia, Impaired Respiratory Function
Phase 2CompletedNovartis Pharmaceuticals1432020-05-272022-07-26
Inhaled Iloprost for Suspected COVID-19 Respiratory Failure
Inhaled ILOPROST - COVID-19, ARDS, Human
Phase 2CompletedHamad Medical Corporation402020-05-232022-03-29

Showing 20 of 61. Sign in to see all of them.

Narrower conditions

COVID-19 (13)  ·  Nasal Obstruction (11)  ·  Respiratory Distress Syndrome (7)  ·  Critical Illness (5)  ·  Coronavirus Infections (4)  ·  Pulmonary Disease, Chronic Obstructive (4)  ·  Airway Obstruction (3)  ·  Sneezing (3)  ·  Acute Lung Injury (2)  ·  Anxiety Disorders (2)  ·  Dyspnea (2)  ·  Obesity Hypoventilation Syndrome (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)

Broader conditions

Respiration Disorders (61)  ·  Respiratory Tract Diseases (61)  ·  Lung Diseases (23)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Infections (20)  ·  Respiratory Tract Infections (16)  ·  Virus Diseases (16)  ·  RNA Virus Infections (15)  ·  Coronaviridae Infections (14)  ·  Nidovirales Infections (14)  ·  Pathologic Processes (14)  ·  Pneumonia (12)  ·  Pneumonia, Viral (12)  ·  Airway Obstruction (11)

Interventions

Standard of Care (4)  ·  Dexmedetomidine (3)  ·  Sodium Chloride (3)  ·  Culture Media (2)  ·  Glucose (2)  ·  Remifentanil (2)  ·  Saline Solution (2)  ·  AZD-3199 (1)  ·  Aspirin (1)  ·  Azithromycin (1)  ·  Capsaicin (1)  ·  Carbon Dioxide (1)  ·  Citrulline (1)  ·  Clopidogrel (1)  ·  Ethanol (1)

Sponsors

GlaxoSmithKline (5)  ·  Novartis Pharmaceuticals (2)  ·  Patrick Murphy (2)  ·  5i Sciences, Inc. (1)  ·  APR Applied Pharma Research s.a. (1)  ·  AbbVie (1)  ·  Abraham Edgar Gracia-Ramos (1)  ·  Al-Azhar University (1)  ·  Asklepion Pharmaceuticals, LLC (1)  ·  AstraZeneca (1)  ·  Australian National University (1)  ·  Bayer (1)  ·  Baylor College of Medicine (1)  ·  Baylor Research Institute (1)  ·  Beth Israel Deaconess Medical Center (1)

Countries

United States (34)  ·  Italy (6)  ·  United Kingdom (5)  ·  Canada (4)  ·  Germany (4)  ·  Australia (3)  ·  Denmark (3)  ·  Brazil (2)  ·  Chile (2)  ·  Mexico (2)  ·  Russia (2)  ·  Sweden (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Egypt (1)

Top investigators

Abraham Edgar Gracia-Ramos, MD MSc (1)  ·  Adrienne Randolph, MD (1)  ·  Ajit Limaye, MD (1)  ·  Amber U Luong, MD, PhD (1)  ·  Ana Martins Valle (1)  ·  Anders Perner, MD, PhD (1)  ·  Boyd Taylor Thompson, MD (1)  ·  Craig Weinert, MD (1)  ·  Edward M. Weaver, MD, MPH (1)  ·  Edward S Schulman, MD (1)  ·  Elisa Perger, MD (1)  ·  Ernest E Moore, MD (1)

Results publications

PMID 31209698, PMID 22791092, PMID 23784924, PMID 23907810, PMID 26728475, PMID 27059469, PMID 27110692, PMID 27178892, PMID 27419080, PMID 28528348, PMID 28606907, PMID 28829877, PMID 29209510, PMID 29800001, PMID 29866165, PMID 30154874, PMID 30558653, PMID 30850876, PMID 30956804, PMID 31119695, PMID 31352795, PMID 31455384, PMID 31741746, PMID 32838109, PMID 32847626, PMID 33287790, PMID 33331622, PMID 33502773, PMID 34473343, PMID 34529182, PMID 34592318, PMID 35244208, PMID 35493119, PMID 36044317, PMID 36104613, PMID 36823164, PMID 37338154, PMID 37355270, PMID 37889107, PMID 38762798, PMID 38865147, PMID 39231898, PMID 39317833, PMID 39432177, PMID 39467285, PMID 41015199, PMID 41788496

NIH funding

2009 (1), 2019 (1), R01HL084139 (1), R01HL130881 (1), R21NR012795 (1), U01HL102547 (1), U10HD036790 (1), UG1HD021364 (1), UG1HD027851 (1), UG1HD027853 (1), UG1HD027880 (1), UG1HD027904 (1), UG1HD034216 (1), UG1HD040492 (1), UG1HD040689 (1)